BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23100875)

  • 1. Lipid metabolism in tumour bearing mice treated withAeromonas L-asparaginase.
    Benny PJ; Kurup GM; Sreejith K
    Indian J Clin Biochem; 1997 Jul; 12(2):108-13. PubMed ID: 23100875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of proteins and glycoproteins in tumour bearing mice treated with Aeromonas L-asparaginase.
    Benny PJ; Muraleedhara KG; Sreejith K; Jayashree G
    Indian J Biochem Biophys; 1996 Dec; 33(6):527-30. PubMed ID: 9219441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of enzymes in leukaemic mice treated withAeromonas L-asparaginase.
    Benny PJ; Muraleedhara Kurup G; Sreejith K
    Indian J Clin Biochem; 1999 Jul; 14(2):189-97. PubMed ID: 23105218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia.
    Cremer P; Lakomek M; Beck W; Prindull G
    Eur J Pediatr; 1988 Jan; 147(1):64-7. PubMed ID: 3422190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood lipid profiles in children with acute lymphoblastic leukemia.
    Halton JM; Nazir DJ; McQueen MJ; Barr RD
    Cancer; 1998 Jul; 83(2):379-84. PubMed ID: 9669823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
    Parsons SK; Skapek SX; Neufeld EJ; Kuhlman C; Young ML; Donnelly M; Brunzell JD; Otvos JD; Sallan SE; Rifai N
    Blood; 1997 Mar; 89(6):1886-95. PubMed ID: 9058708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue nitrogen-sparing effect of high protein diet in mice with or without ascites tumor treated with Acinetobacter glutaminase-asparaginase.
    Kien CL; Anderson AJ; Holcenberg JS
    Cancer Res; 1985 Oct; 45(10):4876-82. PubMed ID: 4027974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the lipid profile in children with acute lymphoblastic leukaemia - the influence of the disease and its treatment].
    Zalewska-Szewczyk B; Matusiak I; Wyka K; Trelińska J; Stolarska M; Młynarski W
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1035-40. PubMed ID: 19531822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.
    Avramis VI; Panosyan EH
    Clin Pharmacokinet; 2005; 44(4):367-93. PubMed ID: 15828851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.
    Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H
    Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced effect of an L-glutamine antagonist, L-(alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, by Acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS
    Cancer Treat Rep; 1979 Jun; 63(6):1109-14. PubMed ID: 466650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid asparagine depletion during pegylated asparaginase therapy in children with acute lymphoblastic leukaemia.
    Henriksen LT; Nersting J; Raja RA; Frandsen TL; Rosthøj S; Schrøder H; Albertsen BK;
    Br J Haematol; 2014 Jul; 166(2):213-20. PubMed ID: 24702187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative pharmacokinetic study of two different ways of using L-asparaginase as the main drug in combination chemotherapy].
    Wang Y; Jiang H; Xie X
    Zhonghua Xue Ye Xue Za Zhi; 1999 Nov; 20(11):589-91. PubMed ID: 11721378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Prednisolone, L-Asparaginase, Gemfibrozil, and Combinations of These Elements on Mice Lipid Profile, Liver, and Pancreas.
    Kose D; Tarakci N; Celik ZE; Vatansev H; Cimbek EA; Ugras S; Sen Y; Caliskan U; Koksal Y
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):e42-9. PubMed ID: 26599986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor inhibitory and non-tumor inhibitory L-asparaginases from Pseudomonas geniculata.
    Kitto GB; Smith G; Thiet TQ; Mason M; Davidson L
    J Bacteriol; 1979 Jan; 137(1):204-12. PubMed ID: 33147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Binding of the antileukemia drug Escherichia coli L-asparaginase to the plasma membrane of normal human mononuclear cells].
    Mercado-Vianco L; Arenas-Díaz G
    Sangre (Barc); 1999 Jun; 44(3):204-9. PubMed ID: 10481582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
    Dessì S; Batetta B; Spano O; Bagby GJ; Tessitore L; Costelli P; Baccino FM; Pani P; Argilès JM
    Br J Cancer; 1995 Nov; 72(5):1138-43. PubMed ID: 7577459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of elaidic acid incorporation upon the lipid composition of Ehrlich Ascites tumor cells and of the host's liver.
    Awad AB
    Lipids; 1978 Dec; 13(12):850-9. PubMed ID: 750825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA-bound lipids of the cells of Zajdela ascites hepatoma and of Ehrlich ascites cancer].
    Struchkov VA; Strazhevskaia NB
    Eksp Onkol; 1989; 11(1):35-9. PubMed ID: 2924707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, characterization and immunogenicity assessment of glutaminase free L-asparaginase from Streptomyces brollosae NEAE-115.
    El-Naggar NE; Deraz SF; El-Ewasy SM; Suddek GM
    BMC Pharmacol Toxicol; 2018 Aug; 19(1):51. PubMed ID: 30139388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.